Rebif 22 multidose
Rebif 22 multidose is a medicine authorised by Swissmedic under authorisation number 60443. The authorisation holder is Merck (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 April 2010 and the authorisation is valid without a time limit. ATC code L03AB07 places the medicine in the group Immunostimulants.
| Authorisation number | 60443 |
|---|---|
| Name | Rebif 22 multidose |
| Full name | Rebif 22 multidose, Injektionslösung in Patronen |
| Authorisation holder | Merck (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L03AB07 |
| First authorisation | 01 April 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rebif 22 multidose, Injektionslösung in Patronen | B | 01 April 2010 |
| 2 | Rebif 44 multidose, Injektionslösung in Patronen | B | 01 April 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 4 | Stück | L03AB07 | 01.99.0. | B |
| 3 | 4 | Stück | L03AB07 | 01.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rebif 22 multidose authorised in Switzerland?
Yes. Rebif 22 multidose is authorised by Swissmedic under authorisation number 60443, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rebif 22 multidose have?
Rebif 22 multidose is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rebif 22 multidose?
The authorisation holder is Merck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.